by Alyson Warr figures by Olivia Foster One in eight women in the United States will develop breast cancer in her lifetime. This statistic makes breast cancer the leading cancer diagnosis for women in the US. With such staggering numbers, a focus on prevention is key: how can we stop breast cancer before it starts? One way is to develop fast and convenient methods of … Continue reading Using Genetics to Fight Cancer: The pros and cons of direct-to-consumer testing
by Catherine Weiner figures by Michael Gerhardt A decade ago, the idea of analyzing your DNA from the comfort of your own home seemed like science fiction. Tests required several weeks, thousands if not millions of dollars, and a lab of highly specialized PhDs. Today, thanks to technical advances and companies like 23andMe, you can perform this analysis for $199. The U.S. Food and Drug … Continue reading What’s in Your Genes: Newly approved genetic testing for disease risks
by Vivian Chou figures by Daniel Utter Donald Trump’s election as the 45th President of the United States has been marked by the brewing storms of racial conflicts. A rise in racial incidents ensued in the immediate aftermath of Trump’s victory in November 2016. Since the beginning of 2017, over 100 bomb threats have been made against Jewish community centers and schools. Trump’s travel ban, signed in … Continue reading How Science and Genetics are Reshaping the Race Debate of the 21st Century
Spitting into a plastic tube normally doesn’t cost $199, but the personal genomics company 23andMe has recently won FDA approval to turn that saliva into a DNA fingerprint. By identifying common variants in our genetic code, 23andMe’s DNA-testing service originally supplied personalized insights into disease predisposition, drug sensitivity, and other health-related traits. In 2013, however, the FDA demanded that 23andMe shutter the health-related aspect of … Continue reading 23andMe wins approval from FDA: What does your DNA say about you?